Streetbeat News

Stock Prices

BONKUSD

DOGEUSD

PEPEUSD

Crypto analyst Kaleo warns that Pepe (CRYPTO: PEPE) is unlikely to reach all-time highs soon, advising against entering a long position until bullish momentum is observed. Kaleo's stance contrasts with analyst Michael Van de Poppe's bullish sentiment from last week, who suggested buying dips and projected a 30% surge for PEPE.

Portfolio Pulse from Mehab Qureshi

December 13, 2023 | 1:00 pm

JCI

Johnson Controls International plc (NYSE:JCI) reported Q4 FY23 sales of $6.91 billion, a 2.7% increase Y/Y but below the consensus of $7.09 billion. Adjusted EPS was $1.05, also below the consensus of $1.09. The company offers a dividend yield of 2.78%, with a quarterly dividend of 37 cents per share. To earn $500 monthly from dividends, an investment of approximately $215,632 or 4,054 shares is needed. JCI shares fell 6% to close at $53.19 on Tuesday after the earnings report.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:58 pm

RSLS

ReShape Lifesciences Inc. (RSLS) shares soared by approximately 45% in pre-market trading due to FDA PMA supplement approval for its Lap-Band 2.0 FLEX. Other stocks also experienced significant movement in pre-market trading, with various gainers such as RiskOn International, Inc. (ROI) and C4 Therapeutics, Inc. (CCCC), and losers including Jin Medical International Ltd. (ZJYL) and Altisource Asset Management Corporation (AAMC).

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:55 pm

DASH

HOV

JPM

RIOT

Insiders at Riot Platforms, JPMorgan Chase, DoorDash, and Hovnanian Enterprises have recently sold significant amounts of shares. These sales could indicate various things, including personal financial management or a lack of confidence in the company's future prospects. Riot Platforms produced more Bitcoin in November, JPMorgan acquired a stake in Indra, DoorDash will join the Nasdaq-100 Index, and Hovnanian reported increased Q4 results.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:55 pm

PFE

SGEN

Pfizer Inc (NYSE:PFE) provided its FY24 guidance, including the financial impact from the Seagen Inc (NASDAQ:SGEN) acquisition. The guidance of $58.5-$61.5 billion in revenue is below the consensus of $63.17 billion. Pfizer expects $8 billion in COVID-19 product revenues and $3.1 billion from Seagen. Adjusted diluted EPS is forecasted at $2.05-$2.25, under the consensus of $3.17. Pfizer also announced a cost savings program and released Phase 2b trial results for its weight loss drug, which had high dropout rates due to side effects. PFE shares dropped 6.86% in premarket trading.

Portfolio Pulse from Vandana Singh

December 13, 2023 | 12:50 pm

META

Meta Platforms, Inc (NASDAQ:META) is launching a fact-checking feature on Threads to combat misinformation ahead of major elections in the U.S. and India. Instagram head Adam Mosseri announced that Threads will use fact-check ratings from Facebook and Instagram and plans to allow fact-checkers to rate misinformation directly on Threads. A new feature will let U.S. users adjust the visibility of fact-checked posts. Threads, which has historically not emphasized news content, will now engage more with news content by introducing tags and trending topics. Details about the fact-checking program are still pending. META shares are trading lower by 0.16% at $333.70 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

December 13, 2023 | 12:45 pm

AGRI

BETS

LFCR

RGF

SANW

The article highlights five consumer staples sector stocks that are considered oversold based on their Relative Strength Index (RSI) values, which are near or below 30. Lifecore Biomedical, Inc. (LFCR), Bit Brother Limited (BETS), The Real Good Food Company, Inc. (RGF), AgriFORCE Growing Systems Ltd. (AGRI), and S&W Seed Company (SANW) have all experienced significant stock price declines recently, presenting potential buying opportunities for undervalued companies.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:44 pm

CCCC

COHR

DHI

DRI

HCAT

JNJ

LULU

NOK

QTWO

TWLO

Wall Street analysts have updated their price targets and ratings for several companies. Nokia's price target was cut by Raymond James, while Q2 Holdings and C4 Therapeutics received price target boosts from Piper Sandler and Stifel, respectively. Lululemon's target was raised by Telsey Advisory Group, and Darden Restaurants' by Keybanc. Barclays increased D.R. Horton's target, JP Morgan raised Health Catalyst's, and Needham boosted Twilio's. Morgan Stanley lifted Coherent Corp.'s target but downgraded the stock, and Wells Fargo cut Johnson & Johnson's target and downgraded the stock.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:44 pm

PLAB

Photronics, Inc (NYSE:PLAB), a semiconductor photomask manufacturer, reported Q4 FY23 revenue of $227.5 million, surpassing the consensus of $224 million, and adjusted EPS of $0.60, beating the consensus of $0.53. The company saw year-over-year growth in both IC and FPD revenues, with a 5.7% increase in gross profit, although margins declined slightly. Photronics provided Q1 guidance with expected revenue and adjusted EPS above consensus estimates. The stock has risen over 29% year-to-date and was up 4.48% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

December 13, 2023 | 12:28 pm

JP Morgan analyst Allen Li has initiated coverage on Kanzhun (NASDAQ:BZ) with an Overweight rating and set a price target of $20 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:28 pm